{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:05:04Z","timestamp":1758272704556,"version":"3.37.3"},"reference-count":40,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100004728","name":"Vellore Institute of Technology","doi-asserted-by":"publisher","award":["VIT\/SG\/2017-18\/93"],"award-info":[{"award-number":["VIT\/SG\/2017-18\/93"]}],"id":[{"id":"10.13039\/501100004728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2020,2,10]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Thrombosis represents as the prime contributor to the burden of diseases,\nworldwide. Conventional anticoagulants for thrombosis therapy have a common bleeding side\neffect. Bioactive peptides are studied to be an effective alternative for currently available\ntherapeutic drugs.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>In this study, VITPOR AI peptide, a previously reported coagulation FXIIa inhibitor\nfrom Nori (Porphyra yezoensis), was assessed for its inhibitory activity against FXIIa and its in\nvivo mode of action.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>In vivo efficacy as well as the antithrombotic property of the peptide was evaluated in\nmice model by ex vivo activated Partial Thromboplastin Time assay, tail transection model and\nwhole blood clotting time. The enzyme kinetics was studied using chromogenic substrate assay.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The kinetic behaviour of VITPOR AI showed that the peptide is a competitive inhibitor of\nFXIIa. Peptide showed significant inhibition of platelet adhesion and aggregation. VITPOR AI\nexhibited significant antithrombotic activity. Furthermore, ex vivo activated Partial Thromboplastin\nTime assay revealed that VITPOR AI exhibited potent anticoagulant activity in vivo. Tail bleeding\nassay revealed that the peptide did not prolong bleeding time in mice even at a higher dose of\n5 mg\/kg. Cytotoxicity studies of the peptide against human blood leukocytes indicated the safety of\nthe peptide.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> VITPOR AI could be prospected as a potent anticoagulant with Factor XIIa inhibition,\nantiplatelet aggregation and antithrombotic activity. It was also studied to have no bleeding side\neffect.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929866526666191026111056","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T16:37:21Z","timestamp":1574095041000},"page":"243-250","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["VITPOR AI, A Coagulation Factor XIIa Inhibitor from Porphyra yezoensis: In Vivo Mode of Action and Assessment of Platelet Function Analysis"],"prefix":"10.2174","volume":"27","author":[{"given":"Kalkooru","family":"L. Venkatraman","sequence":"first","affiliation":[{"name":"Department of Integrative Biology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azeemullah","family":"A. Syed","sequence":"additional","affiliation":[{"name":"Department of Integrative Biology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parimelazhagan","family":"Indumathi","sequence":"additional","affiliation":[{"name":"Department of Integrative Biology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4417-8041","authenticated-orcid":true,"given":"Alka","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Integrative Biology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1126\/science.145.3638.1310","volume":"145","author":"Davie E.W.","year":"1964","unstructured":"Davie E.W.; Ratnoff O.D.; Waterfall sequence for intrinsic blood clotting. Science 1964,145(3638),1310-1312","journal-title":"Science"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1023\/A:1013991828598","volume":"67","author":"Yarovaya G.A.","year":"2002","unstructured":"Yarovaya G.A.; Blokhina T.B.; Neshkova E.A.; Contact system. New concepts on activation mechanisms and bioregulatory functions. Biochemistry (Mosc) 2002,67(1),13-24","journal-title":"Biochemistry (Mosc)"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nature06797","volume":"451","author":"Mackman N.","year":"2008","unstructured":"Mackman N.; Triggers, targets and treatments for thrombosis. Nature 2008,451(7181),914-918","journal-title":"Nature"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/joim.12430","volume":"278","author":"Kenne E.","year":"2015","unstructured":"Kenne E.; Nickel K.F.; Long A.T.; Fuchs T.A.; Stavrou E.X.; Stahl F.R.; Renn\u00e9 T.; Factor XII: A novel target for safe prevention of thrombosis and inflammation. J Intern Med 2015,278(6),571-585","journal-title":"J Intern Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1084\/jem.20091007","volume":"206","author":"Decrem Y.","year":"2009","unstructured":"Decrem Y.; Rath G.; Blasioli V.; Cauchie P.; Robert S.; Beaufays J.; Fr\u00e8re J.M.; Feron O.; Dogn\u00e9 J.M.; Dessy C.; Vanhamme L.; Godfroid E.; Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis. J Exp Med 2009,206(11),2381-2395","journal-title":"J Exp Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1160\/TH04-04-0250","volume":"92","author":"Pauer H.U.","year":"2004","unstructured":"Pauer H.U.; Renn\u00e9 T.; Hemmerlein B.; Legler T.; Fritzlar S.; Adham I.; M\u00fcller-Esterl W.; Emons G.; Sancken U.; Engel W.; Burfeind P.; Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo. Thromb Haemost 2004,92(3),503-508","journal-title":"Thromb Haemost"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1160\/TH06-03-0128","volume":"95","author":"Iwaki T.","year":"2006","unstructured":"Iwaki T.; Castellino F.J.; Plasma levels of bradykinin are suppressed in factor XII-deficient mice. Thromb Haemost 2006,95(6),1003-1010","journal-title":"Thromb Haemost"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1182\/blood-2012-07-292094","volume":"120","author":"Renn\u00e9 T.","year":"2012","unstructured":"Renn\u00e9 T.; Schmaier A.H.; Nickel K.F.; Blomb\u00e4ck M.; Maas C.; \n                        In vivo roles of factor XII. Blood 2012,120(22),4296-4303","journal-title":"Blood"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1016\/j.lfs.2004.12.010","volume":"76","author":"Rajapakse N.","year":"2005","unstructured":"Rajapakse N.; Jung W.K.; Mendis E.; Moon S.H.; Kim S.K.; A novel anticoagulant purified from fish protein hydrolysate inhibits factor XIIa and platelet aggregation. Life Sci 2005,76(22),2607-2619","journal-title":"Life Sci"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.procbio.2007.11.011","volume":"43","author":"Jo H.Y.","year":"2008","unstructured":"Jo H.Y.; Jung W.K.; Kim S.K.; Purification and characterization of a novel anticoagulant peptide from marine echiuroid worm, Urechis unicinctus. Process Biochem 2008,43(2),179-184","journal-title":"Process Biochem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0306-3623(97)00443-6","volume":"31","author":"Koyama T.","year":"1998","unstructured":"Koyama T.; Noguchi K.; Aniya Y.; Sakanashi M.; Analysis for sites of anticoagulant action of plancinin, a new anticoagulant peptide isolated from the starfish Acanthaster planci. Gen Pharmacol 1998,31(2),277-282","journal-title":"Gen Pharmacol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/0041-0101(96)00042-6","volume":"34","author":"Karasudani I.","year":"1996","unstructured":"Karasudani I.; Koyama T.; Nakandakari S.; Aniya Y.; Purification of anticoagulant factor from the spine venom of the crown-of thorns starfish Acanthaster Planci. Toxicon 1996,34(8),871-879","journal-title":"Toxicon"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.foodc hem.2009.04.077","volume":"117","author":"Jung W.","year":"2009","unstructured":"Jung W.; Kim S.; Isolation and characterisation of an anticoagulant oligopeptide from blue mussel Mytilus edulis. Food Chem 2009,117,687-692","journal-title":"Food Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1126\/science.2333510","volume":"248","author":"Waxman L.","year":"1990","unstructured":"Waxman L.; Smith D.E.; Arcuri K.E.; Vlasuk G.P.; Tick Anticoagulant Peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. Science 1990,248(4955),593-596","journal-title":"Science"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00217-017-2946-7","volume":"244","author":"Feng L.","year":"2018","unstructured":"Feng L.; Maolin T.; Meiling Q.; Fengjiao F.; Hui C.; Wei S.; Ming D.; Thrombin inhibitory peptides derived from Mytilus edulis proteins: Identification, molecular docking and in silico prediction of toxicity. Eur Food Res Technol 2018,244(2),207-217","journal-title":"Eur Food Res Technol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10989-018-9682-0","volume":"24","author":"Syed A.A.","year":"2018","unstructured":"Syed A.A.; Mehta A.; Target specific anticoagulant peptides: A Review. Int J Pept Res Ther 2018,24(1),1-12","journal-title":"Int J Pept Res Ther"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10989-013-9353-0","volume":"19","author":"Kong Y.","year":"2013","unstructured":"Kong Y.; Shao Y.; Chen H.; Ming X.; Wang J.B.; Li Z.Y.; Wei J.F.; A novel factor Xa-inhibiting peptide from centipede\u2019s venom. Int J Pept Res Ther 2013,19(4),303-311","journal-title":"Int J Pept Res Ther"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.biochi.2014.07.006","volume":"105","author":"Thakur R.","year":"2014","unstructured":"Thakur R.; Kumar A.; Bose B.; Panda D.; Saikia D.; Chattopadhyay P.; Mukherjee A.K.; A new peptide (Ruviprase) purified from the venom of Daboia russelii russelii shows potent anticoagulant activity via non-enzymatic inhibition of thrombin and factor Xa. Biochimie 2014,105,149-158","journal-title":"Biochimie"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"10846","DOI":"10.1038\/srep10846","volume":"5","author":"Chen M.","year":"2015","unstructured":"Chen M.; Ye X.; Ming X.; Chen Y.; Wang Y.; Su X.; Su W.; Kong Y.; A novel direct factor Xa inhibitory peptide with anti-platelet aggregation activity from Agkistrodon acutus venom hydrolysates. Sci Rep 2015,5,10846","journal-title":"Sci Rep"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jff.2015.11.016","volume":"20","author":"Indumathi P.","year":"2016","unstructured":"Indumathi P.; Mehta A.; A novel anticoagulant peptide from the Nori hydrolysate. J Funct Foods 2016,20,606-617","journal-title":"J Funct Foods"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jmgm.2019.03.019","volume":"89","author":"Syed A.A.","year":"2019","unstructured":"Syed A.A.; Venkatraman K.L.; Mehta A.; An anticoagulant peptide from Porphyra yezoensis inhibits the activity of factor XIIa: In vitro and in silico analysis. J Mol Graph Model 2019,89,225-233","journal-title":"J Mol Graph Model"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1242\/jeb.074211","volume":"215","author":"Ishimaru Y.","year":"2012","unstructured":"Ishimaru Y.; Gomez E.A.; Zhang F.; Martini-Robles L.; Iwata H.; Sakurai T.; Katakura K.; Hashiguchi Y.; Kato H.; Dimiconin, a novel coagulation inhibitor from the kissing bug, Triatoma dimidiata, a vector of Chagas disease. J Exp Biol 2012,215(Pt 20),3597-3602","journal-title":"J Exp Biol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0049-3848(95)93881-Y","volume":"77","author":"Bendar B.C.","year":"1995","unstructured":"Bendar B.C.; Condra R.J.; Platelet aggregation monitored in a 96-well microplate reader is useful for evaluation of platelet agonists and antagonists. Thromb Res 1995,77,453-463","journal-title":"Thromb Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"444-450.15","DOI":"10.1006\/abio.1994.1066","volume":"216","author":"Bellavite P.G.","year":"1994","unstructured":"Bellavite P.G.; Andrioli P.; Guzzo P.; Arigliano S.; Chirumbolo F.; Manzato C.; Santonastaso A colorimetric method for the\nmeasurement of platelet adhesion in microtiter plates. Anal\nBiochem 1994,216,444-450.15","journal-title":"Anal\nBiochem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.cclet.2007.02.014","volume":"18","author":"Yang W.G.","year":"2007","unstructured":"Yang W.G.; Wang Z.; Xu S.Y.; A new method for determination of antithrombotic activity of egg white protein hydrolysate by microplate reader. Chin Chem Lett 2007,18(4),449-451","journal-title":"Chin Chem Lett"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s11746-008-1217-y","volume":"85","author":"Zhang S.B.","year":"2008","unstructured":"Zhang S.B.; Wang Z.; Xu S.Y.; Antioxidant and antithrombotic activities of rapeseed peptides. J Am Oil Chem Soc 2008,85(6),521-527","journal-title":"J Am Oil Chem Soc"},{"key":"ref=27","first-page":"p. (10)3.12.1-3.12.7","volume":"60","author":"Kruisbeek A.M.E.","year":"2004","unstructured":"Kruisbeek A.M.E.;  Proliferative assays for T cells In: Protocols in Immunology, Coligan, E.; Krusibeek, A.M.; Margnlies, D.H.; Shevach, E.M.; Strober, W.; Eds.; Current, John Wiley","journal-title":"Proliferative assays for T cells"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0022-1759 (84)90190-X","volume":"70","author":"Green L.M.","year":"1984","unstructured":"Green L.M.; Reade J.L.; Wade C.F.; Rapid colorimetric assay for cell viability: application to the quantification of cytotoxic and growth inhibitory lymphokines. J Immunol Methods 1984,70,257-268","journal-title":"J Immunol Methods"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.thromres.2006.03.001","volume":"119","author":"Huang J.","year":"2007","unstructured":"Huang J.; Wang S.; Luo X.; Xie Y.; Shi X.; Cinnamaldehyde reduction of platelet aggregation and thrombosis in rodents. Thromb Res 2007,119(3),337-342","journal-title":"Thromb Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1365-2184.2004.00306.x","volume":"37","year":"2004","unstructured":"2Bou-Gharios, G.; Ponticos, M.; Rajkumar, V.; Abraham, D. Extracellular matrix in vascular networks. Cell Prolif 2004,37,207-220","journal-title":"Cell Prolif"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"843","DOI":"10.7326\/0003-4819-124-9-199605010-00010","volume":"124","author":"Cohen M.","year":"1996","unstructured":"Cohen M.; Platelet glycoprotein IIb\/IIIa receptor inhibitors in coronary artery disease. Ann Intern Med 1996,124(9),843-844","journal-title":"Ann Intern Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"12855","DOI":"10.1073\/pnas.0705566104","volume":"104","author":"Pedicord D.L.","year":"2007","unstructured":"Pedicord D.L.; Seiffert D.; Blat Y.; Feedback activation of factor XI by thrombin does not occur in plasma. Proc Natl Acad Sci 2007,104,12855-12860","journal-title":"Proc Natl Acad Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1182\/blood-2013-04-499111","volume":"123","author":"Matafonov A.","year":"2014","unstructured":"Matafonov A.; Leung P.Y.; Gailani A.E.; Grach S.L.; Puy C.; Cheng Q.; Sun M.F.; McCarty O.J.; Tucker E.I.; Kataoka H.; Renn\u00e9 T.; Morrissey J.H.; Gruber A.; Gailani D.; Factor XII inhibition reduces thrombus formation in a primate thrombosis model. Blood 2014,123(11),1739-1746","journal-title":"Blood"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood.V87.6.2337.bloodjournal8762337","volume":"87","author":"Jansen P.M.","year":"1996","unstructured":"Jansen P.M.; Pixley R.A.; Brouwer M.; de Jong I.W.; Chang A.C.; Hack C.E.; Taylor F.B.; Colman R.W.; Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase. Blood 1996,87(6),2337-2344","journal-title":"Blood"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"222ra17-222ra17","DOI":"10.1126\/scitranslmed.3006804","volume":"6","author":"Larsson M.","year":"2014","unstructured":"Larsson M.; Rayzman V.; Nolte M.W.; Nickel K.F.; Bj\u00f6rkqvist J.; J\u00e4ms\u00e4 A.; Hardy MP.; Fries M.; Schmidbauer S.; Hedenqvist P.; Broom\u00e9 M.; A factor XIIa inhibitory antibody provides\nthromboprotection in extracorporeal circulation without increasing\nbleeding risk. Sci Transl Med 2014,6(222),222ra17-222ra17","journal-title":"Sci Transl Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.biochi.2015.02.011","volume":"112","author":"Kato H.","year":"2015","unstructured":"Kato H.; Gomez E.A.; Fujita M.; Ishimaru Y.; Uezato H.; Mimori T.; Iwata H.; Hashiguchi Y.; Ayadualin, a novel RGD peptide with dual antihemostatic activities from the sand fly Lutzomyia ayacuchensis, a vector of Andean-type cutaneous leishmaniasis. Biochimie 2015,112,49-56","journal-title":"Biochimie"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1182\/blood-2013-12-540872","volume":"123","author":"Yau J.W.","year":"2014","unstructured":"Yau J.W.; Liao P.; Fredenburgh J.C.; Stafford A.R.; Revenko A.S.; Monia B.P.; Weitz J.I.; Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits. Blood 2014,123(13),2102-2107","journal-title":"Blood"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1111\/jth.12302","volume":"11","author":"Woodruff R.S.","year":"2013","unstructured":"Woodruff R.S.; Xu Y.; Layzer J.; Wu W.; Ogletree M.L.; Sullenger B.A.; Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer. J Thromb Haemost 2013,11(7),1364-1373","journal-title":"J Thromb Haemost"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1084\/jem.20060217","volume":"203","author":"Colman R.W.","year":"2006","unstructured":"Colman R.W.; Are hemostasis and thrombosis two sides of the same coin? J Exp Med 2006,203(3),493-495","journal-title":"J Exp Med"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/j.1538-7836.2007.02446.x","volume":"5","author":"Gailani D.","year":"2007","unstructured":"Gailani D.; Renn\u00e9 T.; The intrinsic pathway of coagulation: a target for treating thromboembolic disease? J Thromb Haemost 2007,5(6),1106-1112","journal-title":"J Thromb Haemost"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/176194","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T13:48:42Z","timestamp":1583416122000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/176194\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,2,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929866526666191026111056","relation":{},"ISSN":["0929-8665"],"issn-type":[{"type":"print","value":"0929-8665"}],"subject":[],"published":{"date-parts":[[2020,2,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-07-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}